Cite
HARVARD Citation
Levy, B. et al. (2013). KRAS mutations predict sensitivity to pemetrexed-based chemotherapy. Lung cancer management. pp. 275-280. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Levy, B. et al. (2013). KRAS mutations predict sensitivity to pemetrexed-based chemotherapy. Lung cancer management. pp. 275-280. [Online].